Publikace
- Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial2015 | 1. lékařská fakulta, 2. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency2015 | 1. lékařská fakulta
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | 2. lékařská fakulta
- Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry2015 | 1. lékařská fakulta
- Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data2015 | Publikace bez příslušnosti k fakultě
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial2015 | Publikace bez příslušnosti k fakultě
- Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis2014 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni
- Non-Coding Polymorphisms in Nucleotide Binding Domain 1 in ABCC1 Gene Associate with Transcript Level and Survival of Patients with Breast Cancer2014 | 1. lékařská fakulta, 2. lékařská fakulta, 3. lékařská fakulta
- Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines2014 | 1. lékařská fakulta, 2. lékařská fakulta
- The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients2014 | 1. lékařská fakulta, 2. lékařská fakulta
Loading network view...